27.06

4.22% 1.0101

Cassava Sciences Inc (SAVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SAVA Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$26.05

Aprire:

$26.13

Volume 24 ore:

233.81K

Relative Volume:

0.15

Capitalizzazione di mercato:

$1.25B

Reddito:

Utile/perdita netta:

$-97.22M

Rapporto P/E:

-12.36

EPS:

-2.19

Flusso di cassa netto:

$-82.44M

1 W Prestazione:

+3.86%

1M Prestazione:

-5.99%

6M Prestazione:

+21.91%

1 anno Prestazione:

+21.69%

Intervallo 1D:

$26.03

$27.36

Intervallo di 1 settimana:

$25.46

$29.49

Portata 52W:

$8.79

$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Nome

Cassava Sciences Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

512-501-2444

Indirizzo

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

SAVA's Discussions on Twitter

Confronta SAVA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SAVA	27.06	1.25B	0	-97.22M	-82.44M	-2.19
VRTX	446.50	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	739.88	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.80	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	249.97	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	103.80	24.49B	3.30B	-501.07M	1.03B	11.54

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2022-11-16	Downgrade	B. Riley Securities	Buy → Neutral
2021-07-15	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-07-07	Reiterato	Maxim Group	Buy
2021-04-27	Iniziato	B. Riley Securities	Buy
2021-02-16	Reiterato	H.C. Wainwright	Buy
2020-10-23	Iniziato	Cantor Fitzgerald	Overweight
2020-09-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-05-18	Downgrade	H.C. Wainwright	Buy → Neutral
2020-05-15	Downgrade	Maxim Group	Buy → Hold
2020-01-10	Reiterato	Maxim Group	Buy

Mostra tutto

Cassava Sciences Inc Borsa (SAVA) Ultime notizie

Nov 19, 2024

Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? - MSN

Nov 19, 2024

Nov 18, 2024

Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - citybiz

Nov 18, 2024

Cassava Sciences, Inc. Appoints Freda Nassif as Chief Commercial Officer - Marketscreener.com

Nov 18, 2024

Nov 15, 2024

Anavex, Cassava Sciences, Panax Ginseng, And Long-Term Treatment Of Alzheimer's Disease - Seeking Alpha

Nov 11, 2024

Nov 10, 2024

How To Trade (SAVA) - Stock Traders Daily

Nov 10, 2024

Nov 09, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Issues Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Cassava Sciences (NASDAQ:SAVA) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 09, 2024

Nov 08, 2024

Cassava Sciences Q3 2024 Earnings Preview - MSN

Nov 08, 2024

Friday's Top 5 Trending Stocks: What's The Scoop On GameStop, SoFi, Tesla? - Benzinga

Nov 08, 2024

Another U.S. biotech based on Chinese science - STAT

Nov 08, 2024

Cassava Sciences: With Almost Half The Float Shorted, Results Could Be Interesting - Seeking Alpha

Nov 08, 2024

Cassava Sciences nears Alzheimer's drug trial results By Investing.com - Investing.com Canada

Nov 08, 2024

Cassava Sciences’ Q3 2024: Financials and Alzheimer’s Trials Progress - TipRanks

Nov 08, 2024

Nov 07, 2024

Cassava Sciences: Pivotal Alzheimer’s Data May Push Stock Toward Book Value (SAVA) - Seeking Alpha

Nov 07, 2024

Cassava Q3 Earnings Review: It Feels Like The End May Be Nigh (NASDAQ:SAVA) - Seeking Alpha

Nov 07, 2024

Looking At Cassava Sciences's Recent Unusual Options Activity - Benzinga

Nov 07, 2024

Cassava Sciences nears Alzheimer's drug trial results - Investing.com India

Nov 07, 2024

Cassava Sciences stock in focus after earnings (SAVA:NASDAQ) - Seeking Alpha

Nov 07, 2024

Cassava Sciences Reports Q3 2024 Financial and Operating Results - The Manila Times

Nov 07, 2024

Nov 06, 2024

Cassava Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024

Nov 05, 2024

Cassava Sciences (NASDAQ:SAVA) Trading Down 5.8%Should You Sell? - MarketBeat

Nov 05, 2024

Unpacking the Latest Options Trading Trends in Cassava Sciences - Benzinga

Nov 05, 2024

Nov 04, 2024

Analysts Believe Cassava Sciences Now Has 300% Upside From Here - MSN

Nov 04, 2024

Nov 01, 2024

Cassava Sciences (SAVA) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - GlobeNewswire

Oct 31, 2024

International Assets Investment Management LLC Makes New Investment in Cassava Sciences, Inc. (NASDAQ:SAVA) - MarketBeat

Oct 31, 2024

Oct 30, 2024

Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Yahoo Finance

Oct 30, 2024

Long Term Trading Analysis for (SAVA) - Stock Traders Daily

Oct 30, 2024

Oct 26, 2024

HC Wainwright & Co. Upgrades Cassava Sciences (SAVA) - MSN

Oct 26, 2024

Oct 24, 2024

Cassava Sciences Options Trading: A Deep Dive into Market Sentiment - Benzinga

Oct 24, 2024

Oct 21, 2024

Institutions profited after Cassava Sciences, Inc.'s (NASDAQ:SAVA) market cap rose US$72m last week but individual investors profited the most - Simply Wall St

Oct 21, 2024

Oct 19, 2024

(SAVA) Proactive Strategies - Stock Traders Daily

Oct 19, 2024

Oct 17, 2024